You are here

Heart Failure


More Stories

Congestion in heart failure patients is associated with increased mortality risk

Patients with acute decompensated heart failure who had severe congestion during and after hospitalization had an increased risk of mortality and morbidity, according to a post-hoc analysis of two clinical trials.

CRT-D in older adults improves survival compared with ICD alone

After one and four years, older patients with heart failure were more likely to be alive if they received cardiac resynchronization therapy with defibrillator (CRT-D) compared with a group who received only an implantable cardioverter-defibrillator (ICD), according to a registry analysis.

Hospice care referral for heart failure leads to lower hospital readmissions

Medicare beneficiaries who were hospitalized for heart failure were less likely to be readmitted within 30 days if they were referred to hospice care, according to an analysis of data from Alabama hospitals. Within six months of hospital discharge, most of the patients who had died were not referred to receive hospice care.



Hospitalization, death rates high for HF patients with preserved ejection fraction

Nearly one-third of patients who were hospitalized with heart failure with preserved ejection fraction died during a follow-up period of 49.5 months, according to a randomized study.

HRS.15: Baroreflex activation therapy improves quality of life in heart failure patients

BOSTON—A novel approach known as baroreflex activation therapy led to a 30 percent improvement in New York Heart Association  classification and an increase in quality of life among patients with heart failure and reduced ejection fraction who had failed previous therapies.

FDA issues another recall for HeartWare

The FDA issued a Class I recall on a component of the HeartWare Ventricular Assist System. This latest recall targets a splice repair kit that fails when exposed to excessive force.

Mental stress in HF patients leads to increase in heart rate, blood pressure

Mental stress among heart failure patients led to a significant increase in heart rate and diastolic and systolic blood pressure in a study of patients who prepared and gave a speech about their personal strengths and weaknesses.

More than 10% of patients hospitalized for HF have worsening symptoms

Approximately 10 percent to 15 percent of patients had worsening heart failure or died within five days of being admitted into a hospital for acute heart failure, according to a pooled analysis of clinical trials.

Wine may improve spirits but not outcomes for heart failure patients

Moderate wine consumption may lighten the outlook for patients with chronic heart failure but it may not make any difference in long-term outcomes, based on results from a large Italian study.

Cognitive decline is common after LVAD implantation

Nearly one-third of patients had cognitive decline one year after undergoing left ventricular assist device (LVAD) implantation for advanced heart failure, according to an analysis of a large, multicenter, observational registry

Low health literacy associated with increased risk of death in acute HF patients

Patients with acute heart failure had an increased risk of all-cause mortality after being discharged from the hospital if they had a low level of health literacy, according to a retrospective study. After adjusting for various factors, the risk of death for patients with low health literacy was 32 percent higher than for patients with higher health literacy.

Hodgkin lymphoma survivors at high risk of cardiovascular diseases

People with Hodgkin lymphoma have a high risk for various cardiovascular diseases for decades after their initial diagnosis, according to a retrospective cohort study.

Heart failure incidence dips 37.5% over 10 years

The incidence of heart failure dropped steeply over a decade in a population-based study, and while hospitalization rates remained steady over time, causes shifted from cardiovascular to noncardiovascular.

FDA approves ivabradine for heart failure patients

The FDA approved ivabradine to reduce the risk of hospitalization in patients with heart failure. The agency had expedited its evaluation of the drug under its priority review program.

FDA panel favors heart failure warning on saxagliptin’s labeling

An FDA advisory panel recommended that labeling for the diabetes drug saxagliptin include a warning about a risk of heart failure. The panel determined that the drug’s overall cardiovascular risk was acceptable.

Phenomapping analysis identifies groups of heart failure patients

A phenomapping analysis of patients hospitalized for heart failure found that heart failure with preserved ejection fraction is a heterogeneous disorder and contains mutually exclusive groups with similar characteristics.

Statement on treating patients with hypertension and heart failure

The statement from the American Heart Association (AHA), American College of Cardiology (ACC) and American Society of Hypertension (ASH) updated guidelines from 2007.

Analysis shows 15% of HeartWare recipients develop gastro bleeding

Approximately 15 percent of patients with advanced heart failure experienced gastrointestinal bleeding after receiving the HeartWare Ventricular Assist Device System. However, none of the events impacted survival, and no surgical intervention was needed.

Stroke risk may be high for some patients with heart failure but no a-fib

While guidelines warn against giving anticoagulation to patients with heart failure but without atrial fibrillation, there may be some evidence that a subgroup of these patients may be at increased risk for stroke and could benefit from additional therapy.

Caregivers of destination LVAD patients benefit from support, too

Patients aren’t the only ones impacted by destination therapy left ventricle assist device (LVAD) implants. Caregivers should be part of decision-making and they need support and tools to help them process the change, according to a study.